×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
0
Days
0
Hours
0
Minutes
0
Seconds


Monday, September 22nd 2025
01pm to 01:45pm (GMT+2)

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
Add to calendar Notify me
 Browser notifications are enabled

Intervenants :

 

Pr Jean-Sébastien Frenel

Dr Frédéric Selle

 

Programme :

 

- Présentation des recommandations sur la maintenance, avec un focus sur le choix des différents niveaux de preuve.

- Pourquoi avoir choisi de partir des contre-indications au BEV, ce qui fait l'originalité de ces recommandations comparées à celles de l'ASCO/ESMO ?

- Quelle maintenance CC0 vs non-CC0, pN+, notion de haut risque vs bas risque, pour qui le BEV ?

- Débat/Discussion & Réponses aux questions

 

Shooting date : 2025-09-22
Last update : 2025-08-11
Jean-Sébastien Frenel
Saint-Herblain, France
Oncology
Frédéric Selle
Paris, France
Oncology

Suggestions

Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
Honolulu : Wednesday, January 22nd 2025 from 06am to 07am (GMT+1)
San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)

Prise en charge des cancers de l'ovaire en rechute :

état des lieux et perspectives

Share
Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Honolulu : Wednesday, May 18th 2022 from 06:30am to 08am (GMT+2)
San Francisco : Wednesday, May 18th 2022 from 09:30am to 11am (GMT+2)
New York : Wednesday, May 18th 2022 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
Reykjavik : Wednesday, May 18th 2022 from 04:30pm to 06pm (GMT+2)
London / Dublin : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Istanbul : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
Bangkok : Wednesday, May 18th 2022 from 11:30pm to 01am (GMT+2)
Shanghai : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
Tokyo : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
Sydney : Thursday, May 19th 2022 from 03:30am to 05am (GMT+2)
Wellington : Thursday, May 19th 2022 from 05:30am to 07am (GMT+2)

Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire

Share
Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT+1)
New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+1)

Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

Share
Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

Cycle d'enseignement sur le cancer de l'ovaire - Première session

Share
Scroll Up